Global and United States Sugar Coated Tablets Market Research by Company, Type & Application 2013-2025
SUMMARY
Sugar Coated Tablets are coated with a colored or an uncolored sugar layer. The coating is water soluble and quickly dissolves after swallowing. The sugar-coating protects the encapsulated drug from the environment and provides a barrier to objectionable tablet taste or odor.
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Sugar Coated Tablets are coated with a colored or an uncolored sugar layer. The coating is water soluble and quickly dissolves after swallowing. The sugar-coating protects the encapsulated drug from the environment and provides a barrier to objectionable tablet taste or odor.
Market Segment as follows:
By Type
- Colored Sugar Coated Tablets
- Colorless Sugar Coated Tablets
- Cardiovascular Diseases
- Gastrointestinal Disease
- Neurological Diseases
- Immune Disease
- Others
- Pfizer
- Novartis
- Yangze River Pharmacelltcal
- Bayer
- XINHUA PHARMACEUTICAL
- Harbin Pharmaceutical
- Eisai
- NCPC
- GSK
- Gebro
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Colored Sugar Coated Tablets
1.1.2.2 Colorless Sugar Coated Tablets
1.1.3 Market by Application
1.1.3.1 Cardiovascular Diseases
1.1.3.2 Gastrointestinal Disease
1.1.3.3 Neurological Diseases
1.1.3.4 Immune Disease
1.1.3.5 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Novartis
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Yangze River Pharmacelltcal
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Bayer
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 XINHUA PHARMACEUTICAL
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Harbin Pharmaceutical
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Eisai
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 NCPC
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 GSK
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Gebro
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Colored Sugar Coated Tablets
1.1.2.2 Colorless Sugar Coated Tablets
1.1.3 Market by Application
1.1.3.1 Cardiovascular Diseases
1.1.3.2 Gastrointestinal Disease
1.1.3.3 Neurological Diseases
1.1.3.4 Immune Disease
1.1.3.5 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Novartis
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Yangze River Pharmacelltcal
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Bayer
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 XINHUA PHARMACEUTICAL
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Harbin Pharmaceutical
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Eisai
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 NCPC
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 GSK
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Gebro
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Yangze River Pharmacelltcal
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer
Table Sales Revenue, Volume, Price, Cost and Margin of XINHUA PHARMACEUTICAL
Table Sales Revenue, Volume, Price, Cost and Margin of Harbin Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai
Table Sales Revenue, Volume, Price, Cost and Margin of NCPC
Table Sales Revenue, Volume, Price, Cost and Margin of GSK
Table Sales Revenue, Volume, Price, Cost and Margin of Gebro
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Yangze River Pharmacelltcal
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer
Table Sales Revenue, Volume, Price, Cost and Margin of XINHUA PHARMACEUTICAL
Table Sales Revenue, Volume, Price, Cost and Margin of Harbin Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai
Table Sales Revenue, Volume, Price, Cost and Margin of NCPC
Table Sales Revenue, Volume, Price, Cost and Margin of GSK
Table Sales Revenue, Volume, Price, Cost and Margin of Gebro
LIST OF FIGURES
Figure Colored Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Colored Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Colored Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Colored Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Colorless Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Colorless Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Colorless Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Colorless Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Cardiovascular Diseases Market Size and CAGR 2013-2017 (Million USD)
Figure Cardiovascular Diseases Market Size and CAGR 2013-2017 (Volume)
Figure Cardiovascular Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cardiovascular Diseases Market Forecast and CAGR 2018-2025 (Volume)
Figure Gastrointestinal Disease Market Size and CAGR 2013-2017 (Million USD)
Figure Gastrointestinal Disease Market Size and CAGR 2013-2017 (Volume)
Figure Gastrointestinal Disease Market Forecast and CAGR 2018-2025 (Million USD)
Figure Gastrointestinal Disease Market Forecast and CAGR 2018-2025 (Volume)
Figure Neurological Diseases Market Size and CAGR 2013-2017 (Million USD)
Figure Neurological Diseases Market Size and CAGR 2013-2017 (Volume)
Figure Neurological Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Figure Neurological Diseases Market Forecast and CAGR 2018-2025 (Volume)
Figure Immune Disease Market Size and CAGR 2013-2017 (Million USD)
Figure Immune Disease Market Size and CAGR 2013-2017 (Volume)
Figure Immune Disease Market Forecast and CAGR 2018-2025 (Million USD)
Figure Immune Disease Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Global Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Global Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure United States Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure United States Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Sugar Coated Tablets SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure Colored Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Colored Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Colored Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Colored Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Colorless Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Colorless Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Colorless Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Colorless Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Cardiovascular Diseases Market Size and CAGR 2013-2017 (Million USD)
Figure Cardiovascular Diseases Market Size and CAGR 2013-2017 (Volume)
Figure Cardiovascular Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cardiovascular Diseases Market Forecast and CAGR 2018-2025 (Volume)
Figure Gastrointestinal Disease Market Size and CAGR 2013-2017 (Million USD)
Figure Gastrointestinal Disease Market Size and CAGR 2013-2017 (Volume)
Figure Gastrointestinal Disease Market Forecast and CAGR 2018-2025 (Million USD)
Figure Gastrointestinal Disease Market Forecast and CAGR 2018-2025 (Volume)
Figure Neurological Diseases Market Size and CAGR 2013-2017 (Million USD)
Figure Neurological Diseases Market Size and CAGR 2013-2017 (Volume)
Figure Neurological Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Figure Neurological Diseases Market Forecast and CAGR 2018-2025 (Volume)
Figure Immune Disease Market Size and CAGR 2013-2017 (Million USD)
Figure Immune Disease Market Size and CAGR 2013-2017 (Volume)
Figure Immune Disease Market Forecast and CAGR 2018-2025 (Million USD)
Figure Immune Disease Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure Global Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure Global Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Sugar Coated Tablets Market Size and CAGR 2013-2017 (Million USD)
Figure United States Sugar Coated Tablets Market Size and CAGR 2013-2017 (Volume)
Figure United States Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Sugar Coated Tablets Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Sugar Coated Tablets SWOT List
Figure Healthcare & Medical Porter's Five Forces
